Studies comparing Thromboelastography or Rotational thromboelastometry versus standard coagulation tests are abundant. Data comparing the two exclusively in a liver intensive care set up is limited. Studies show that TEG and ROTEM cannot be used interchangeably in trauma, liver transplant patients, but there is limited evidence of the same in critically ill cirrhotic patients. In this study, the investigators tried to demonstrate the comparison of blood products used to treat coagulopathy based on TEG versus ROTEM algorithms in cirrhotic patients presenting with non variceal bleeding
Thromboelastography (TEG) and thromboelastometry( ROTEM) are point-of-care, global hemostasis assessment tests that measure the viscoelastic changes that occur during the hemostatic process. Patients with cirrhosis have an imbalance of procoagulants and anticoagulants combined with alterations in fibrinolysis ,platelet number and function. Point of care viscoelastic tests (TEG ,ROTEM) demonstrate specific functional coagulation defects that can direct blood component transfusion therapy in cirrhosis, with clinical validation of individual parameters. Studies comparing Thromboelastography or Rotational thromboelastometry versus standard coagulation tests are abundant. Data comparing the two exclusively in a liver intensive care set up is limited. Studies show that TEG and ROTEM cannot be used interchangeably in trauma, liver transplant patients, but there is limited evidence of the same in critically ill cirrhotic patients. In this study, the investigators tried to demonstrate the comparison of blood products used to treat coagulopathy based on TEG versus ROTEM algorithms in cirrhotic patients presenting with non variceal bleeding
Study Type
OBSERVATIONAL
Enrollment
60
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Total amount of blood products transfused at 8 hours(FFP, Cryoprecipitate, platelets) will be measured
Total amount of blood products transfused at 8 hours(FFP, Cryoprecipitate, platelets) will be measured
Time frame: 8 hours
R time of thromboelastography
R time measures time to start forming clot
Time frame: 8 hours
K time of thromboelastography
K time represents time until clot reaches a fixed strength
Time frame: 8 hours
alpha angle of thromboelastography
alpha angle represents speed of fibrin accumulation
Time frame: 8 hours
Maximum amplitude of thromboleastography
It represents the highest vertical amplitude of thromboelastography
Time frame: 8 hours
LY30 Iin thromboelastometry
It represents the percentage of amplitude reduction 30 minutes after reaching maximum amplitude
Time frame: 8 hours
Clotting time in thromboelastometry
It represents the time to start forming clot and initial fibrin formation
Time frame: 8 hours
Clot formation time in thromboelastometry
It represents the clot strengthening and rapidity of fibrin build up
Time frame: 8 hours
Maximum clot firmness in thromboelastometry
It represents the highest vertical amplitude of the thromboelastometry graph and represents clot strength
Time frame: 8 hours
LI30 in thromboelastometry
It represents clot breakdown and fibrinolysis at fixed time
Time frame: 8 hours
Control of bleeding at 48 hours
The investigators would measure the hemoglobin levels to see for any drop in concentration of hemoglobin
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.